Impfstoff-Verteilung: Pandemie hält durch Ungleichheit an tagesschau.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tagesschau.de Daily Mail and Mail on Sunday newspapers.
By Maggie Fick NAIROBI (Reuters) - After a stressful year working as a doctor at Kenya s largest public hospital in the midst of the COVID-19 pandemic, Ngala Mwendwa got his first dose of the AstraZeneca vaccine in March and breathed a sigh of relief. The Indian-manufactured shot was supplied by COVAX, a global vaccine initiative that s been a lifeline for poor African nations. But with India now engulfed in its own crisis, Mwendwa has no idea when he will get his second dose. It s just the way we are disadvantaged as a third world country, he told Reuters after a shift in Kenyatta National Hospital s paediatric intensive care ward. It s scary. Before it was hit by the world s highest numbers of daily infections, India had been vital to global vaccination efforts. Its Serum Institute of India, the world s biggest producer of the AstraZeneca vaccine, was the cornerstone of COVAX s supply chain. But sources told Reuters this week that India s vaccine exports, halted in March, are unlikel